Noncardiogenic pulmonary edema triggered by intravenous immunoglobulin in cancer-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

Nephron

Volumn 77, Issue 3, 1997, Pages 368-370

  Suassuna, José H R ^a,b   Da Costa, Mário Alberto D L ^c   Faria, Ricardo A ^a   Melichar, Ana C ^b  

^a Hospital São Lucas FAG   (Brazil)

^b HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; CASE REPORT; HEMOLYTIC UREMIC SYNDROME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LARGE CELL CARCINOMA; LETTER; LUNG EDEMA; MALE; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; NEOPLASMS; PULMONARY EDEMA; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 0030669143     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190309     Document Type: Letter

References (15)

1. Cantrell JE Jr., Phillips TM, Schein PS: Carcinoma-associated hemolytic-uremic syndrome: A complication of mitomycin C chemotherapy. J Clin Oncol 1985;3:723-734.
2. Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, Arbus M, Woolley PV. Chiazze L. Schein PS, Neefe JR: Cancer-associated hemolytic uremic syndrome: Analysis of 85 cases from a national registry. J Clin Oncol 1989;7:781-789.
3. Hayward CPM, Sutton DMC, Carter WH Jr, Campbell ED, Scott JG, Francombe WH, Shu-mak KH, Baker MA: Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Arch Intern Med 1994; 154:982-987.
4. Jolivet J, Giroux L, Laurin S, Gruber J, Bettez P, Band PR: Microangiopathic hemolytic anemia. renal failure, and noncardiogenic pulmonary edema: A chemotherapy-induced syndrome. Cancer Treat Rep 1983:67:429-434.
5. Viero P, Cortelazzo S, Buelli M, Comotti B, Minetti B, Bassan R, Barbui T: Thrombotic thrombocytopenic purpura and high-dose immunoglobulin treatment. Ann Intern Med 1986; 104:282.
6. Finn NG, Wang JC. Hong KJ: High-dose intravenous γ-immunoglobulin infusion in the treatment of thrombotic thrombocytopenic purpura. Arch Intern Med 1987;147:2165-2167.
7. Lian ECY, Mui P, Siddiqui FA. Chin AYY, Chin LLS: Inhibition of platelet aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G. J Clin Invest 1984;73:548-555.
8. Jordan SC: Intravenous γ-globulin therapy in systemic lupus erythematosus and immune complex disease. Clin Immunol Immunopathol 1989;53:S164-S169.
9. Kuhlman JE, Kavuru M, Fishman EK, Siegel-man SS:Pneumocystis carinii pneumonia: Spectrum of parenchymal CT findings. Radiology 1990;175:711-714.
10. Morgan PW, Goodman LR: Pulmonary edema and adult respiratory distress syndrome. Radiol Clin North Am 1991;29:943-963.
11. Primack SL, Müller NL, Mayo JR, Remy-Jar-din M, Remy J: Pulmonary parenchymal abnormalities of vascular origin: High-resolution CT findings. Radiographics 1994:14:739-746.
12. Rault R, Piraino B, Johnston JR. Oral A: Pulmonary and renal toxicity of intravenous immunoglobulin. Clin Nephrol 1991;36:83-86.
13. Crandall ED, Staub NC, Goldberg HS, Effros RM: Recent developments in pulmonary edema. Ann Intern Med 1983;99:808-822.
14. Silvestris F, Cafforio P, Dammacco F: Pathogenic anti-DNA idiotype-reactive IgG in intravenous immunoglobulin preparations. Clin Exp Immunol 1994;97:19-25.
15. Nielsen H: Immunoglobulin preparations for intravenous administration. A review of their biologic activities and comparison of various preparation methods. Allergy 1994:121:88-95.